メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
河合 秀樹
医学部・循環器内科学
h-index
3497
被引用数
18
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2006
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(61)
類似のプロファイル
(6)
フィンガープリント
Hideki Kawaiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Coronary Computed Tomography Angiography
100%
Computed Tomography Angiography
99%
Computer Assisted Tomography
63%
Revascularization
51%
Chronic Kidney Disease
46%
Acute Decompensated Heart Failure
44%
Fractional Flow Reserve
43%
Intravascular Ultrasound
41%
Stenosis
40%
Coronary Artery
37%
Coronary Artery Disease
35%
Coronary Artery Obstruction
32%
Heart Muscle Ischemia
31%
Heart Failure with Preserved Ejection Fraction
30%
Heart Failure
29%
Cardiac Sarcoidosis
28%
Optical Coherence Tomography
28%
D-Dimer
28%
Carotid Artery
28%
Intensive Care Unit
28%
Fulminant
28%
Myocarditis
28%
Acute Coronary Syndrome
25%
Ejection Fraction
24%
Heart Left Ventricle Ejection Fraction
23%
Coronary Angiography
21%
Echocardiography
18%
Statin
17%
Myocardial Infarction
17%
Cardiovascular System
17%
Two Dimensional Speckle Tracking Echocardiography
16%
Fluorodeoxyglucose
16%
Thromboembolism
16%
Adverse Outcome
16%
Creatinine
16%
Kidney Function
16%
Omega-3 Fatty Acid
15%
Percutaneous Coronary Intervention
15%
Multimodality Imaging
15%
Carotid Artery Stenting
14%
Heat Shock Protein 72
14%
Plaque Characterization
14%
Carotid Endarterectomy
14%
COVID-19
14%
near Infrared Spectroscopy
14%
ST Elevation
14%
Catheterization
14%
Amino Terminal Sequence
14%
Brain Natriuretic Peptide
14%
Heart Muscle Injury
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Failure
39%
Acute Coronary Syndrome
34%
Statin (Protein)
32%
Chronic Kidney Failure
31%
Heart Failure with Preserved Ejection Fraction
30%
Brain Natriuretic Peptide
28%
Acute Kidney Failure
28%
Lancovutide
28%
Rivaroxaban
28%
Heart Failure
27%
Pitavastatin
26%
Cardiovascular Disease
22%
Disease
19%
Creatinine
18%
Adverse Outcome
18%
Coronary Artery Disease
15%
Cause of Death
14%
Heat Shock Protein 72
14%
Membrane Phospholipid
14%
Acetylsalicylic Acid
14%
Atherosclerosis
14%
Antithrombotic Therapy
14%
C Reactive Protein
14%
Prevalence
14%
Cardiovascular Risk
14%
Troponin T
14%
Icosapentaenoic Acid
14%
Coronavirinae
14%
Rapamycin
14%
Hemodialysis
14%
D Dimer
14%
Spinocerebellar Degeneration
14%
Heart Failure with Reduced Ejection Fraction
14%
Low Density Lipoprotein Cholesterol
14%
Fatty Acid Binding Protein
14%
Omega-3 Fatty Acid
14%
Myosin Binding Protein C
14%
Heart Muscle Ischemia
14%
Warfarin
12%
Antiplatelet
12%
Biological Marker
10%
All Cause Mortality
9%
Upacicalcet
9%
Heart Left Ventricle Failure
7%
Survival Rate
6%
Major Adverse Cardiac Event
6%
Docosahexaenoic Acid
5%
Pandemic
5%
Kidney Disease
5%
Lipocortin 5
5%
Keyphrases
Coronary Computed Tomography Angiography
46%
Cardiac Intensive Care Unit
28%
Carotid Revascularization
28%
Clinical Outcomes
28%
Acute Coronary Syndrome
19%
Computed Tomography Angiography
19%
Stenosis
16%
Adverse Cardiac Events
15%
Sirolimus-eluting Stent
14%
Acute Kidney Injury
14%
Mild Chronic Kidney Disease
14%
Fatty
14%
Syndrome-based
14%
Primary Stenting
14%
Coronary Plaque Characteristics
14%
Antithrombotic Therapy
14%
Eicosapentaenoic Acid to Arachidonic Acid Ratio
14%
Multimarker Approach
14%
Future Hospital
14%
High-sensitivity Troponin I
14%
Injury Associations
14%
Bleeding Complications
14%
Coronary Artery Stenosis
14%
Major Bleeding
14%
Coronary Artery Stenting
14%
PET Analysis
14%
Echocardiographic Parameters
14%
Renal Angina Index
14%
Non-target Organisms
14%
Isolated Cardiac Sarcoidosis
14%
Duramycin
14%
Radiation Burden
14%
Coronary Sinus
14%
Portal-systemic Collaterals
14%
Coil Migration
14%
Percutaneous Transhepatic Obliteration
14%
Significant Coronary Artery Disease
14%
Urinary Liver-type Fatty Acid Binding Protein
14%
FFRCT
14%
Stable Cardiovascular Disease
14%
Phospholipid Asymmetry
14%
Eicosapentaenoic Acid
14%
On-site Assessment
14%
Angiography-derived Fractional Flow Reserve
14%
Invasive Fractional Flow Reserve
14%
Mid-term Follow-up
14%
Rivaroxaban
14%
Myocardial Mass
14%
Grayscale
14%
Angiographic Characteristics
14%
